Nurse Practitioner, Family · Hampton, VA
NPI
1184195562
Since 2018
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
915 Gloucester St
Hampton, VA, 23661
Phone (757) 694-5306
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$166K
1,460 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Sharee L Stowes prescribed most often to Medicare patients was Losartan Potassium, with 94 prescriptions and refills. In total Sharee L Stowes wrote 1,460 Medicare prescriptions that cost $166K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-12-11.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Losartan Potassium Generic | 94 | 94 | 14 | $2,690 |
| Gabapentin Generic | 50 | 50 | Under 11 | $840 |
| Furosemide Generic | 50 | 50 | Under 11 | $537 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 45 | 45 | Under 11 | $1,328 |
| Ezetimibe Generic | 45 | 45 | Under 11 | $1,206 |
| Amlodipine Besylate Generic | 43 | 43 | Under 11 | $1,033 |
| Atorvastatin Calcium Generic | 43 | 43 | 11 | $1,299 |
| Farxiga Dapagliflozin Propanediol | 42 | 42 | Under 11 | $14K |
| Hydralazine Hcl Generic | 39 | 39 | Under 11 | $1,249 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 39 | 39 | Under 11 | $17K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 35 | 35 | Under 11 | $13K |
| Famotidine Generic | 34 | 34 | Under 11 | $1,082 |
| Carvedilol Generic | 31 | 31 | Under 11 | $937 |
| Xarelto Rivaroxaban | 29 | 29 | Under 11 | $8,812 |
| Metformin Hcl Er Metformin Hcl | 29 | 29 | Under 11 | $592 |
Brand drugs: 375 claims; generic drugs: 1,069 claims; opioid claims: 17.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Sharee L Stowes were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.